FdaApplication

BLA 125196

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSchering Corporation a subsidiary of Merck & Co., Inc.
application_typeBLA
approval_date2008-06-13

Products (4)

ProductActive ingredientStrengthDosage form
PEGINTRON/ REBETOL COMBO PACK—80MCG/0.5ML & 200MG—
PEGINTRON/ REBETOL COMBO PACK—120MCG/0.5ML & 200MG—
PEGINTRON/ REBETOL COMBO PACK—150MCG/0.5ML & 200MG—
PEGINTRON/ REBETOL COMBO PACK—50MCG/0.5ML & 200MG—

4 products